Search For
19 result(s) for 'Immune checkpoint inhibitors'
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
Open Access Review 12 Sep 2024
DOI: 10.20517/cdr.2024.77
Views: Downloads:
The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
Open Access Review 10 Jun 2024
Views: Downloads:
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Open Access Original Article 13 Mar 2024
Views: Downloads:
Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma
Open Access Review 27 Dec 2023
DOI: 10.20517/cdr.2023.89
Views: Downloads:
Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies
Open Access Review 16 Nov 2023
DOI: 10.20517/cdr.2023.58
Views: Downloads:
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
Open Access Review 25 Sep 2023
DOI: 10.20517/cdr.2023.39
Views: Downloads:
Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena
Open Access Review 19 Sep 2023
DOI: 10.20517/cdr.2023.47
Views: Downloads:
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors
Open Access Review 26 Jun 2023
DOI: 10.20517/cdr.2023.02
Views: Downloads:
Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
Open Access Review 13 Jun 2023
DOI: 10.20517/cdr.2023.13
Views: Downloads:
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
Open Access Commentary 29 May 2023
Views: Downloads:
Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer
Open Access Review 11 May 2022
DOI: 10.20517/cdr.2022.13
Views: Downloads:
Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer
Open Access Review 7 Feb 2022
Views: Downloads:
- 1
- 2